Accutar

Accutar Biotechnology Receives NMPA Clearance of IND Application for AC0682 in ER-Positive Breast Cancer

BROOKLYN, N.Y. & SHANGHAI - Accutar Biotechnology, Inc., a clinical stage biotechnology company focu...

  • 3 years ago

Find us here